自殺防止薬の世界市場（2022年～2028年）

世界の自殺防止薬の市場規模は、予測期間中に4.1%の大幅なCAGRで成長すると予測されています。市場の成長を後押しする主な要因には、抗うつ薬や抗精神病薬に対する需要の高まり、ライフスタイルの変化、主に若年層の間で高い自殺傾向を助長する社会的圧力の増加、心理療法に対する需要の高まりなどが挙げられます。

当レポートでは、世界の自殺防止薬市場を調査しており、市場の概要、市場動向の分析、薬剤タイプ別・流通チャネル別・地域別の分析、競合情勢、さらに主要企業のプロファイルなど、包括的な情報を提供しています。

目次

第1章 レポートの概要

第2章 市場概要と見解

• 調査範囲
• アナリストの見解と現在の市場動向

第3章 競合情勢

• 主要企業分析
  • 概要
  • 財務分析
  • SWOT分析
  • 最近の開発
• 主要戦略分析
• 主要企業へのCOVID-19の影響

第4章 市場セグメンテーション

• 世界の自殺防止薬市場：薬剤タイプ別
  • 抗うつ薬・抗不安薬
  • N-メチルアスパラギン酸受容体拮抗薬
  • 抗生物質アナログ
  • 抗精神病薬
  • その他
• 世界の自殺防止薬市場：流通チャネル別
  • オンライン
  • オフライン

第5章 地域分析

• 北米
  • 米国
  • カナダ
• 欧州
  • 英国
  • ドイツ
  • イタリア
  • スペイン
  • フランス
  • その他の欧州
• アジア太平洋
  • 中国
  • インド
  • 日本
  • その他のアジア太平洋
• その他の地域

第6章 企業プロファイル

• Allergan Inc.
• AstraZeneca
• Eli Lilly and Co.
• Pfizer Inc.
• H. LUNDBECK A/S
• Johnson & Johnson Services, Inc.
• Merck & Co., Inc.
• NRx Pharmaceuticals, Inc.
• VistaGen Therapeutics

LIST OF TABLES

• 1. GLOBAL ANTI SUICIDAL DRUG MARKET RESEARCH AND ANALYSIS BY DRUG CLASS, 2021-2028 ($ MILLION)
• 2. GLOBAL ANTI-DEPRESSANT & ANTI-ANXIETY SUICIDAL DRUG MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
• 3. GLOBAL N-METHYL-D-ASPARTATE RECEPTOR ANTAGONISTS ANTI SUICIDAL DRUG MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
• 4. GLOBAL ANTIBIOTIC ANALOG SUICIDAL DRUG MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
• 5. GLOBAL ANTI-PSYCHOTIC SUICIDAL DRUG MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
• 6. GLOBAL OTHERS ANTI SUICIDAL DRUG MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
• 7. GLOBAL ANTI SUICIDAL DRUG MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2021-2028 ($ MILLION)
• 8. GLOBAL ONLINE ANTI SUICIDAL DRUG MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
• 9. GLOBAL OFFLINE ANTI SUICIDAL DRUG MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
• 10. GLOBAL ANTI SUICIDAL DRUG MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2021-2028 ($ MILLION)
• 11. NORTH AMERICAN ANTI SUICIDAL DRUG MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
• 12. NORTH AMERICAN ANTI SUICIDAL DRUG MARKET RESEARCH AND ANALYSIS BY DRUG CLASS, 2021-2028 ($ MILLION)
• 13. NORTH AMERICAN ANTI SUICIDAL DRUG MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2021-2028 ($ MILLION)
• 14. EUROPEAN ANTI SUICIDAL DRUG MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
• 15. EUROPEAN ANTI SUICIDAL DRUG MARKET RESEARCH AND ANALYSIS BY DRUG CLASS, 2021-2028 ($ MILLION)
• 16. EUROPEAN ANTI SUICIDAL DRUG MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2021-2028 ($ MILLION)
• 17. ASIA-PACIFIC ANTI SUICIDAL DRUG MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
• 18. ASIA-PACIFIC ANTI SUICIDAL DRUG MARKET RESEARCH AND ANALYSIS BY DRUG CLASS, 2021-2028 ($ MILLION)
• 19. ASIA-PACIFIC ANTI SUICIDAL DRUG MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2021-2028 ($ MILLION)
• 20. REST OF THE WORLD ANTI SUICIDAL DRUG MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
• 21. REST OF THE WORLD ANTI SUICIDAL DRUG MARKET RESEARCH AND ANALYSIS BY DRUG TYPE, 2021-2028 ($ MILLION)
• 22. REST OF THE WORLD ANTI SUICIDAL DRUG MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2021-2028 ($ MILLION)

LIST OF FIGURES

• 1. IMPACT OF COVID-19 ON GLOBAL ANTI SUICIDAL DRUG MARKET, 2021-2028 ($ MILLION)
• 2. IMPACT OF COVID-19 ON GLOBAL ANTI SUICIDAL DRUG MARKET BY SEGMENT, 2021-2028 ($ MILLION)
• 3. RECOVERY OF GLOBAL ANTI SUICIDAL DRUG MARKET, 2022-2028 (%)
• 4. GLOBAL ANTI SUICIDAL DRUG MARKET SHARE BY DRUG CLASS, 2021 VS 2028 (%)
• 5. GLOBAL ANTI-DEPRESSANT & ANTI-ANXIETY ANTI-SUICIDAL DRUG MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
• 6. GLOBAL N-METHYL-D-ASPARTATE RECEPTOR ANTAGONISTS ANTI SUICIDAL DRUG MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
• 7. GLOBAL ANTIBIOTIC ANALOG ANTI SUICIDAL DRUG MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
• 8. GLOBAL ANTI-PSYCHOTIC ANTI SUICIDAL DRUG MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
• 9. GLOBAL OTHERS ANTI SUICIDAL DRUG MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
• 10. GLOBAL ANTI SUICIDAL DRUG MARKET SHARE BY DISTRIBUTION CHANNEL, 2021 VS 2028 (%)
• 11. GLOBAL ONLINE ANTI SUICIDAL DRUG MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
• 12. GLOBAL OFFLINE ANTI SUICIDAL DRUG MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
• 13. GLOBAL ANTI SUICIDAL DRUG MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
• 14. US ANTI SUICIDAL DRUG MARKET SIZE, 2021-2028 ($ MILLION)
• 15. CANADA ANTI SUICIDAL DRUG MARKET SIZE, 2021-2028 ($ MILLION)
• 16. UK ANTI SUICIDAL DRUG MARKET SIZE, 2021-2028 ($ MILLION)
• 17. FRANCE ANTI SUICIDAL DRUG MARKET SIZE, 2021-2028 ($ MILLION)
• 18. GERMANY ANTI SUICIDAL DRUG MARKET SIZE, 2021-2028 ($ MILLION)
• 19. ITALY ANTI SUICIDAL DRUG MARKET SIZE, 2021-2028 ($ MILLION)
• 20. SPAIN ANTI SUICIDAL DRUG MARKET SIZE, 2021-2028 ($ MILLION)
• 21. REST OF EUROPE ANTI SUICIDAL DRUG MARKET SIZE, 2021-2028 ($ MILLION)
• 22. INDIA ANTI SUICIDAL DRUG MARKET SIZE, 2021-2028 ($ MILLION)
• 23. CHINA ANTI SUICIDAL DRUG MARKET SIZE, 2021-2028 ($ MILLION)
• 24. JAPAN ANTI SUICIDAL DRUG MARKET SIZE, 2021-2028 ($ MILLION)
• 25. REST OF ASIA-PACIFIC ANTI SUICIDAL DRUG MARKET SIZE, 2021-2028 ($ MILLION)
• 26. REST OF THE WORLD ANTI SUICIDAL DRUG MARKET SIZE, 2021-2028 ($ MILLION)

Global Anti suicidal drugs Market Size, Share & Trends Analysis Report By Drug Type (Anti -Depressant & Anti-Anxiety Drug, N-Methyl-D-Aspartate(NMDA) Receptor Antagonists, Antibiotic Analog, Anti-Psychotic Drug, and Others), and By Distribution Channel (Online, and Offline) Forecast 2022-2028

The global anti suicidal drugs market is anticipated to grow at a substantial CAGR of 4.1% during the forecast period. Depression is considered the major healthcare problem leading to lower productivity and to build suicidal tendencies. Increasing demand for anti-depressant and anti-psychotic drugs is supporting the market growth. These drugs support the prevention of suicidal thoughts and attempts. Moreover, the global anti suicidal drugs market is increasing due to the changing lifestyle, and increasing societal pressures aid in the high suicidal tendencies, primarily among young adults. Suicidal tendencies are indicated to be higher among women than in men. Demand for psychotherapy for the treatment of this condition is increasing which in turn is likely to contribute to the growth of the anti-suicide drugs market.

The global anti suicidal drugs market is segmented based on the drug type, and distribution channel. Based on the drug type, the market is segmented into anti -depressant & anti-anxiety drug, N-Methyl-D-Aspartate receptor antagonists, antibiotic analog, anti-psychotic drug, and others. Based on the distribution channel, the market is sub-segmented into online and offline. Amongst the drug type, N-Methyl-D-Aspartate receptor antagonists drug market is anticipated to grow more in the forecasted period. Based on the distribution channel, the offline pharmacies distributed anti suicidal drugs market is anticipated to grow more in the projected forecast period.

The global anti suicidal drugs market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. North America is anticipated to hold a significant share in the global anti suicidal drugs market. This is due to their developed healthcare infrastructure and early adoption of new therapies. Additionally, the increasing healthcare expenditure in emerging economies and the high prevalence of suicides will boost the market growth in this region.

The major companies serving the global anti suicidal drugs market include Allergan, AstraZeneca, Eli Lilly and Co., GlaxoSmithKline, Pfizer Inc., and many more. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, collaborations, funding, and new product launches for the advancement of the product, to stay competitive in the market. For instance, in May 2018, Takeda Pharmaceutical Co. Ltd. and H. Lundbeck A/S had received the US Food and Drug Administration (FDA) approvable for a supplemental new drug application for TRINTELLIX (vortioxetine) in order to provide treatment for acute major depressive disorder.

Research Methodology

The market study of the global anti suicidal drugs market is incorporated by extensive primary and secondary research conducted by the research team at OMR. Secondary research has been conducted to refine the available data to breakdown the market into various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives as possible, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.

Secondary Sources Include:

• Financial reports of companies involved in the market.
• Whitepapers, research papers, and news blogs.
• Company websites and their product catalogue.

The report provides an in-depth analysis of market size, intended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models.

Market Segmentation

1. Global Anti Suicidal Drugs Market Research And Analysis by Drug Type

2. Global Anti Suicidal Drugs Market Research And Analysis by Distribution Channel

The Report Covers:

• Comprehensive Research Methodology of the global anti suicidal drugs market.
• This report also includes a detailed and extensive market overview with key analyst insights.
• An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
• Analysis of regional regulations and other government policies impacting the global anti suicidal drugs market.
• Insights about market determinants that are stimulating the global anti suicidal drugs market.
• Detailed and extensive market segments with the regional distribution of forecasted revenues.
• Extensive profiles and recent developments of market players.

Table of Contents

1. Report Summary

• Current Industry Analysis and Growth Potential Outlook
• Impact of COVID-19 on The Global Anti Suicidal Drug Market
• Recovery Scenario of Global Anti Suicidal Drug Market
• 1.1. Research Methods and Tools
• 1.2. Market Breakdown
  • 1.2.1. By Segments
  • 1.2.2. BY Region

2. Market Overview and Insights

• 2.1. Scope of the Report
• 2.2. Analyst Insight & Current Market Trends
  • 2.2.1. Key Findings
  • 2.2.2. Recommendations
  • 2.2.3. Conclusion

3. Competitive Landscape

• 3.1. Key Company Analysis
  • 3.1.1. Overview
  • 3.1.2. Financial Analysis
  • 3.1.3. SWOT Analysis
  • 3.1.4. Recent Developments
• 3.2. Key Strategy Analysis
• 3.3. Impact of Covid-19 on Key Players

4. Market Segmentation

• 4.1. Global Anti Suicidal Drug Market by Drug Type
  • 4.1.1. Anti-Depressant & Anti-Anxiety Drug
  • 4.1.2. N-Methyl-Aspartate Receptor Antagonists
  • 4.1.3. Antibiotic Analog
  • 4.1.4. Anti-Psychotic Drug
  • 4.1.5. Others
• 4.2. Global Anti Suicidal Drug Market by Distribution Channel
  • 4.2.1. Online
  • 4.2.2. Offline s

5. Regional Analysis

• 5.1. North America
  • 5.1.1. United States
  • 5.1.2. Canada
• 5.2. Europe
  • 5.2.1. UK
  • 5.2.2. Germany
  • 5.2.3. Italy
  • 5.2.4. Spain
  • 5.2.5. France
  • 5.2.6. Rest of Europe
• 5.3. Asia-Pacific
  • 5.3.1. China
  • 5.3.2. India
  • 5.3.3. Japan
  • 5.3.4. Rest of Asia-Pacific
• 5.4. Rest of the World

6. Company Profiles

• 6.1. Allergan Inc.
• 6.2. AstraZeneca
• 6.3. Eli Lilly and Co.
• 6.4. Pfizer Inc.
• 6.5. H. LUNDBECK A/S
• 6.6. Johnson & Johnson Services, Inc.
• 6.7. Merck & Co., Inc.
• 6.8. NRx Pharmaceuticals, Inc.
• 6.9. VistaGen Therapeutics